1. Home
  2. SONM vs BIVI Comparison

SONM vs BIVI Comparison

Compare SONM & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • BIVI
  • Stock Information
  • Founded
  • SONM 1999
  • BIVI 2013
  • Country
  • SONM United States
  • BIVI United States
  • Employees
  • SONM N/A
  • BIVI N/A
  • Industry
  • SONM Telecommunications Equipment
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • BIVI Health Care
  • Exchange
  • SONM Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • SONM 12.1M
  • BIVI 11.9M
  • IPO Year
  • SONM 2019
  • BIVI N/A
  • Fundamental
  • Price
  • SONM $0.71
  • BIVI $1.87
  • Analyst Decision
  • SONM
  • BIVI
  • Analyst Count
  • SONM 0
  • BIVI 0
  • Target Price
  • SONM N/A
  • BIVI N/A
  • AVG Volume (30 Days)
  • SONM 306.1K
  • BIVI 308.9K
  • Earning Date
  • SONM 11-12-2025
  • BIVI 11-12-2025
  • Dividend Yield
  • SONM N/A
  • BIVI N/A
  • EPS Growth
  • SONM N/A
  • BIVI N/A
  • EPS
  • SONM N/A
  • BIVI N/A
  • Revenue
  • SONM $57,917,000.00
  • BIVI N/A
  • Revenue This Year
  • SONM $127.68
  • BIVI N/A
  • Revenue Next Year
  • SONM N/A
  • BIVI N/A
  • P/E Ratio
  • SONM N/A
  • BIVI N/A
  • Revenue Growth
  • SONM N/A
  • BIVI N/A
  • 52 Week Low
  • SONM $0.52
  • BIVI $1.42
  • 52 Week High
  • SONM $6.38
  • BIVI $75.00
  • Technical
  • Relative Strength Index (RSI)
  • SONM 60.23
  • BIVI 35.82
  • Support Level
  • SONM $0.67
  • BIVI $1.72
  • Resistance Level
  • SONM $0.79
  • BIVI $1.95
  • Average True Range (ATR)
  • SONM 0.06
  • BIVI 0.15
  • MACD
  • SONM 0.02
  • BIVI 0.21
  • Stochastic Oscillator
  • SONM 64.89
  • BIVI 73.77

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: